Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab long-term continuation study in SLE
NCT00712933Phase 3Completed
- Sponsor
- GSK
- Start
- May 2008
- Primary completion
- Dec 2016
- Countries
- 28
01
Overview
A Phase 3 trial of belimumab in systemic lupus erythematosus (SLE), sponsored by GSK. Started May 2008; status: completed.
02
Drugs
belimumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT00712933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00712933.